Arthritis, whether osteoarthritis (OA) or rheumatoid arthritis (RA), involves joint pain, inflammation, stiffness, and progressive tissue changes that can significantly affect mobility and quality of life. Photobiomodulation (PBM), also known as red light therapy or low level light therapy (LLLT), has been studied for decades as a potential supportive therapy for arthritis-related symptoms.
What the Research Shows
Rheumatoid Arthritis
Some of the strongest early evidence for PBM in arthritis comes from rheumatoid arthritis research. A Cochrane Review evaluating low level laser therapy for RA found evidence of short term improvements in pain and morning stiffness compared to placebo treatment. The review reported meaningful reductions in pain intensity and duration of morning stiffness in several clinical trials, although study sizes and treatment protocols varied considerably.
Researchers noted that benefits appeared most consistent for symptom relief rather than long term disease modification, and larger standardized studies are still needed.
Osteoarthritis
Research on osteoarthritis, particularly knee OA, has also produced encouraging findings. Multiple randomized controlled trials have reported reductions in pain scores and improvements in mobility and physical function following PBM treatment.
A 2019 systematic review and meta analysis published in BMJ Open concluded that photobiomodulation showed beneficial effects for knee osteoarthritis pain in several placebo controlled studies. However, the authors also emphasized substantial variation between treatment protocols, wavelengths, dosing methods, and device types across the literature.
Proposed Mechanisms
Researchers believe photobiomodulation may influence arthritis symptoms through several biological pathways. Proposed mechanisms include modulation of inflammatory signaling, reduction of oxidative stress within joint tissues, support for mitochondrial energy production, and effects on circulation and cellular repair processes.
Laboratory studies have also suggested that PBM may influence inflammatory cytokines such as TNF-α, IL-1β, and IL-6, while potentially supporting chondrocyte activity and tissue recovery within the joint environment. These mechanisms remain an active area of ongoing research.
How PBM May Influence Arthritis Symptoms
Inflammatory Signaling → May help regulate inflammatory pathways within joint tissue
Oxidative Stress → May reduce oxidative stress associated with joint inflammation
Mitochondrial Support → May support cellular energy production and recovery
Circulation Effects → May influence blood flow and tissue oxygenation
Joint Recovery → May support chondrocyte activity and broader tissue repair processes
Best Wavelengths for Arthritis
Because joints are deeper structures than skin, near infrared wavelengths are often emphasized in arthritis protocols due to their greater tissue penetration. Much of the arthritis research has focused on wavelengths in the 810nm to 850nm range, while visible red wavelengths around 630nm to 660nm may contribute to more superficial tissue effects.
The MitoPRO 1500X covers 830nm and 850nm alongside visible red wavelengths. The MitoADAPT MAX 4.0 adds 810nm — one of the most studied wavelengths for joint inflammation — making it particularly well-suited for arthritis protocols.
| Wavelength | Common Arthritis Focus |
|---|---|
| 630–660nm Red Light | Superficial tissue and skin-level effects |
| 810nm Near Infrared | Joint inflammation and deep tissue research |
| 830nm Near Infrared | Musculoskeletal and arthritis-related PBM studies |
| 850nm Near Infrared | Deep tissue penetration, joints, and recovery |
Protocol Recommendations
Treatment protocols for arthritis vary substantially depending on the device, wavelength, irradiance, treatment area, and severity of symptoms. Many studies use sessions several times per week with the light positioned close to the affected joint for short treatment durations.
Consistency appears to matter more than excessively long sessions. Some users report gradual improvements in pain, stiffness, and mobility over several weeks of regular use, although results vary significantly between individuals.
Because arthritis is a complex medical condition, photobiomodulation should generally be viewed as a supportive wellness tool rather than a replacement for medical treatment, exercise therapy, or prescribed medications.
Key Points
- Arthritis PBM protocols vary widely between studies and devices
- Most research uses short sessions several times per week
- Treatment is typically applied close to the affected joint
- Consistency appears more important than excessively long sessions
- PBM is best viewed as a supportive wellness tool alongside medical care and exercise therapy
The Bottom Line
Red light therapy is one of the more extensively studied musculoskeletal applications of photobiomodulation. Evidence is strongest for short term symptom relief in rheumatoid arthritis and promising for osteoarthritis, particularly knee OA. While the current research is encouraging, study quality and treatment protocols remain inconsistent, and larger standardized clinical trials are still needed.
For people managing arthritis related discomfort, PBM may be a useful adjunctive wellness approach alongside clinician guided treatment and lifestyle strategies.
Medical Disclaimer: This article is intended for general wellness and educational purposes only and is not medical advice. Research on photobiomodulation and red light therapy is ongoing, and responses may vary between individuals. Consult a qualified healthcare professional regarding injuries, chronic pain, eye conditions, or medical concerns before beginning any new wellness protocol.
Affiliate Disclosure: Some links on this page are affiliate links. If you purchase through them, we may earn a small commission at no extra cost to you. We only recommend products we have independently evaluated.
FAQ
Can red light therapy help arthritis pain?
Research suggests photobiomodulation may help reduce arthritis-related pain and stiffness, particularly in rheumatoid arthritis and knee osteoarthritis. Many studies focus on symptom relief and mobility improvements rather than reversing the underlying condition.
What wavelengths are best for arthritis treatment?
Near-infrared wavelengths between 810nm and 850nm are commonly studied for arthritis because they penetrate deeper into joint tissue. Red light in the 630–660nm range may support more superficial tissue effects.
Does red light therapy work for rheumatoid arthritis?
Some clinical studies and reviews have reported short-term improvements in pain and morning stiffness in people with rheumatoid arthritis. Researchers continue to study its long-term effectiveness and optimal treatment protocols.
How often should you use red light therapy for arthritis?
Many arthritis studies use short treatment sessions several times per week with the light positioned close to the affected joint. Consistency over time appears more important than very long treatment sessions.
Is red light therapy a replacement for arthritis medication?
No. Photobiomodulation is generally viewed as a supportive wellness tool alongside medical treatment, exercise therapy, and prescribed medications. People with arthritis should continue following guidance from their healthcare provider.
Research References
Cochrane Review on low-level laser therapy for rheumatoid arthritis https://www.cochrane.org/evidence/CD002049_low-level-laser-therapy-rheumatoid-arthritis
Effects of low-level laser therapy in adults with rheumatoid arthritis: a systematic review and meta-analysis of controlled trials https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0291345
Effectiveness of Photobiomodulation in Reducing Pain and Disability in Patients with Knee Osteoarthritis: A Systematic Review with Meta-Analysis https://academic.oup.com/ptj/article/104/8/pzae073/7679396?login=false&guestAccessKey=
Association of photobiomodulation therapy (PBMT) and exercises programs in pain and functional capacity of patients with knee osteoarthritis (KOA): a systematic review of randomized trials https://link.springer.com/article/10.1007/s10103-020-03223-8
Mechanisms and applications of the anti-inflammatory effects of photobiomodulation https://pmc.ncbi.nlm.nih.gov/articles/PMC5523874/
